Efficacy of FGFR Inhibitors and Combination Therapies for Acquired Resistance in FGFR2-Fusion CholangiocarcinomaMelanie A. Krook, Sameek Roychowdhury, Michele R. Wing et al.|Molecular Cancer Therapeutics|2020Cited by 138
Ewing Sarcoma and Osteosarcoma Have Distinct Immune Signatures and Intercellular Communication NetworksAnthony R. Cillo, Kelly M. Bailey|Clinical Cancer Research|2022Cited by 85
Future Directions and Priorities for Cellular Therapy in Sarcoma: A Report from the Strategic Advances in Sarcoma Science Cell Therapy BreakoutJacqueline Oliva, Seth M. Pollack, David Milewski et al.|Cancers|2025Cited by 2
PARP inhibition in Ewing sarcoma: impact of germline DNA damage repair defects and activation of immunoregulatory pathwaysLisa M. Maurer, Kelly M. Bailey|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 1